Elixir Medical

Sunnyvale, United States Founded: 2005 • Age: 21 yrs
Drug eluting stents

About Elixir Medical

Elixir Medical is a Healthcare company based in Sunnyvale (United States) founded in 2005. Drug eluting stents. Elixir Medical has raised $5.3 million across 1 funding round from investors including Invus. The company has 70 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity in India is Elixir Medcorp India Private Limited (U33110DL2012FTC230915).

Company details

Elixir Medical, a privately held company headquartered in Sunnyvale, CA, is developing drug-eluting stent systems. Key products include the Novolimus Eluting Stent System and Bioresorbable Coronary Scaffold System. The products are only approved for use outside the US.

Key Metrics
  • Total Equity Funding
    $5.3M (USD)

    in 1 rounds

  • Latest Funding Round
    $5.3M (USD), Series A

    Mar 2005

  • Investors
  • Employee Count
    70

Funding Insights of Elixir Medical

Elixir Medical has successfully raised a total of $5.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.3 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.3M
  • Total Rounds 1
  • Last Round Series A β€” $5.3M
  • First Round $5.3M

    (Mar 2005)

  • Investors Count 1

All 1 funding rounds of Elixir Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2005$5.3MSeries A––
Valuation history

1 investors in total: 1 institutional.

Investors in Elixir Medical

Elixir Medical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invus.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Long-term private equity investments in transformational opportunities are pursued.
invus.comNew York, United States
Premium access

Investor details for Elixir Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Elixir Medcorp India Private Limited (Elixir Medical)

Elixir Medcorp India Private Limited is the primary company behind Elixir Medical. The board of Elixir Medcorp India Private Limited currently have 2 directors; the longest-serving is Motasim Sirhan, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Motasim Sirhan
DIN 05107062
Director02 Feb 201214 yrs 9 moElixir Medcorp India Private Limited
Jonas Miguel Fajgenbaum
DIN 05107055
Director02 Feb 201214 yrs 9 moElixir Medcorp India Private Limited

People of Elixir Medical

35 people are tracked at Elixir Medical (21 in leadership, 14 in team); the tracked headcount is 70.

NameRoleGroup
Brian McBerry
Director Of Sales Operations And Supply ChainLeadership
Founder & Chief Executive OfficerLeadership
Sean Fryman
Associate Director, Quality EngineeringLeadership
Alex Nepogodiev
Executive Vice President Strategy And MarketingLeadership
Vinayak Bhat
President & Chief Operating OfficerLeadership
Elizabeth Lau Ph.D.
Director Clinical ResearchLeadership
Candace Elek
Executive Vice President, Clinical ResearchLeadership
Sam Omaleki
Sr. Vice President, OperationsLeadership
Grant Choe
Director Of MarketingLeadership
Armando Garza
VP R&dLeadership
Erin Mazzone
Vice President, Regulatory And QualityLeadership
Ginger Autry
Director Clinical ResearchLeadership
Gretchen Wilderspin
Senior Director Clinical ResearchLeadership
Laurie Moncrief
Vp, Human ResourcesLeadership
John Pustell
Vice President OperationsLeadership
Germaine Guenard
Vice President Human ResourcesLeadership
Joaquin Azpilicueta
Medical DirectorLeadership
Max Muhs
Executive Regional Vice PresidentLeadership
Chris Ryan
Vice President, Commercial Strategy And ExecutionLeadership
Horia Grosu
Sr. Director Of Commercial OperationsLeadership

15 more people are available in the full profile.

Premium access

Complete people profiles for Elixir Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Elixir Medical

2 dated milestones of Elixir Medical, from founding to its latest funding, stage changes and deals.

  1. Founded Elixir Medical is founded.
  2. Funding First funding round of $5.3M.

Web traffic of Elixir Medical

The website of Elixir Medical (elixirmedical.com) receives about 6.3K visits a month.

  • Monthly visits
    6.3K

    ▲ 19% vs previous month

Similar websites

Websites whose visitors overlap most with Elixir Medical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
allbiomedical.com
100%
View details
biotronik.com
95%
128.7K#316,493View details
medicaldevice-network.com
95%
#456,669View details
medison.co.il
medison.co.il
63%
–
medisonpharma.com
63%
3.4K#5,039,615View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Elixir Medical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Elixir Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Elixir Medical

Premium access

Complete news archive for Elixir Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elixir Medical

Elixir Medical was founded in 2005.

Elixir Medical is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.

Elixir Medical is a funded company, having raised a total of $5.3M across 1 funding round to date. The company's 1st funding round was a Series A of $5.3M, raised on Mar 2005.

Elixir Medical has 70 employees.

Elixir Medical, a privately held company headquartered in Sunnyvale, CA, is developing drug-eluting stent systems. Key products include the Novolimus Eluting Stent System and Bioresorbable Coronary Scaffold System. The products are only approved for use outside the US.

Elixir Medical has 1 investor. Key investors include Invus.

Elixir Medical operates through Elixir Medcorp India Private Limited.

The legal entities of Elixir Medical currently have 2 directors, including Motasim Sirhan, Jonas Miguel Fajgenbaum.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available